$BSBR

Banco Santander (Brasil) S.A.

0
0
1
—
$118K
Ishii Michele Soares
0%
See all $BSBR insider activity →
Low

Brazil Weighs Loan Limits as Debt Hits 49.9%

Brazil's central bank is considering income-linked limits on unsecured credit as household debt reaches 49.9% of 12-month income. The plan, not yet confirmed, would require lenders to assess borrowers' ability to pay and disclose terms clearly. Affected US-listed banks include Itaú (ITUB), Bradesco (BBD), Nubank (NU), and Santander Brasil (BSBR).

Viani Ede Ilson sold $290K of BSBR

Viani Ede Ilson (VP Exec Officer) sold 50,000 shares of Banco Santander (Brasil) S.A. (BSBR) at $5.79 ($0.29M total) on 2026-09-22.

BSBR sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning BSBR (Banco Santander (Brasil) S.A.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent BSBR coverage spans insider activity, market movers and macro economy.

In the last 30 days, BSBR insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($118K). The most active reporter was Ishii Michele Soares, Officer w/o Specific Desig, with 1 filing.

What's driving BSBR

AlphAI scores every news story that mentions BSBR with an AI model for sentiment and relevance, and aggregates insider trades from Banco Santander (Brasil) S.A.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BSBR

Score

Brazil Weighs Loan Limits as Debt Hits 49.9%

Brazil's central bank is considering income-linked limits on unsecured credit as household debt reaches 49.9% of 12-month income. The plan, not yet confirmed, would require lenders to assess borrowers' ability to pay and disclose terms clearly. Affected US-listed banks include Itaú (ITUB), Bradesco (BBD), Nubank (NU), and Santander Brasil (BSBR).

$CLLSMed

This Cellectis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Cellectis (NASDAQ:CL

Analysts downgraded several stocks: HSBC cut Banco Santander Brasil (BSBR) to Hold with a $6.2 target; Rosenblatt downgraded Ribbon Communications (RBBN) to Neutral with a $2.2 target; Citizens downgraded Cellectis (CLLS) to Market Perform; Barclays downgraded Scholar Rock (SRRK) to Equal-Weight with a $58 target; Raymond James downgraded Ascendis Pharma (ASND) to Outperform with a $287 target.

Related tickers